Browse studies

Find your next paid study

5 recruiting studies matching your filters

Phase 2 Study of Golcadomide With Rituximab as a Bridging Therapy Prior to CAR-T for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

This phase II trial tests the effectiveness of golcadomide and rituximab as bridging treatment before chimeric antigen receptor (CAR) T-cell therapy in patient…

Large B-Cell Lymphoma With IRF4 RearrangementRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent ALK-Positive Large B-Cell Lymphoma+28 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06834373

Phase 2

Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

This is a prospective cohort study of 12 overweight (with one or more weight-related condition) or obese adults with well controlled HIV-1 on antiretroviral th…

Obesity and OverweightHIVChronic Inflammation

Estimated

~$10 – $6,250

University of HawaiiNCT06935838

MicroRNA Regulation of Chronic Inflammation During Aging

This is an observational study enrolling healthy individuals aged 18-35 and 65y and older to determine the health of immune cells in the blood and how these ce…

Chronic Inflammation

Estimated

~$10 – $750

University of UtahNCT05392582

Phase 1

A Phase 1 Study of SynKIR-310, Autologous T Cells Transduced With CD19 KIR-CAR, in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

This first-in-human (FIH) trial is designed to assess the safety, feasibility and preliminary efficacy of a single intravenous (IV) dose of SynKIR-310 administ…

B Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more

Estimated

~$10 – $8,750

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1

This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how…

Obesity, MorbidNASH - Nonalcoholic SteatohepatitisChronic Inflammation

Estimated

~$10 – $750

Mayo ClinicNCT04232566